Advertisement
Canada markets close in 5 hours 11 minutes
  • S&P/TSX

    22,191.19
    -99.43 (-0.45%)
     
  • S&P 500

    5,190.44
    +2.74 (+0.05%)
     
  • DOW

    38,962.40
    +78.14 (+0.20%)
     
  • CAD/USD

    0.7286
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    78.40
    +0.02 (+0.03%)
     
  • Bitcoin CAD

    85,968.91
    -1,221.58 (-1.40%)
     
  • CMC Crypto 200

    1,327.29
    +32.62 (+2.52%)
     
  • GOLD FUTURES

    2,324.30
    +0.10 (+0.00%)
     
  • RUSSELL 2000

    2,052.77
    -11.88 (-0.58%)
     
  • 10-Yr Bond

    4.4820
    +0.0190 (+0.43%)
     
  • NASDAQ

    16,335.20
    +2.64 (+0.02%)
     
  • VOLATILITY

    13.20
    -0.03 (-0.23%)
     
  • FTSE

    8,360.43
    +46.76 (+0.56%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • CAD/EUR

    0.6775
    +0.0004 (+0.06%)
     

Is Novartis a Good Stock to Buy Right Now?

Is Novartis a Good Stock to Buy Right Now?

Novartis (NYSE: NVS) is a company in transition. Now, Novartis is close to completing this long-winded transition with the upcoming spin-off of its generic drug business, Sandoz, later this year. With a debt-to-equity ratio of 47%, Novartis' balance sheet isn't overly levered, especially compared to many of its big pharma peers.